# FDA Inspection 1035729 - Mayne Pharma International PTY LTD - September 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/mayne-pharma-international-pty-ltd/c5e66e29-41e1-4d52-af2f-eccec193cf77
Source feed: FDA_Inspections

> FDA inspection 1035729 of Mayne Pharma International PTY LTD, September 15, 2017. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035729
- Company Name: Mayne Pharma International PTY LTD
- Inspection Date: 2017-09-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1257835 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/mayne-pharma-international-pty-ltd/fb195325-06ba-4ffd-90e0-c4c64fbcbfc5)
- FDA Inspection 1110711 - 2019-10-18
- FDA Inspection 945811 - 2015-09-25
- FDA Inspection 846520 - 2013-08-02
- FDA Inspection 588986 - 2009-05-15

Company: https://www.keypedia.com/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c